AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 51 filers reported holding AGILE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $49,000 | -92.8% | 37,000 | -88.8% | 0.00% | -100.0% |
| Q1 2021 | $685,000 | -9.7% | 329,300 | +24.5% | 0.00% | 0.0% |
| Q4 2020 | $759,000 | -5.2% | 264,400 | +0.4% | 0.00% | 0.0% |
| Q3 2020 | $801,000 | +62.5% | 263,400 | +48.5% | 0.00% | +100.0% |
| Q2 2020 | $493,000 | +235.4% | 177,400 | +124.8% | 0.00% | 0.0% |
| Q1 2020 | $147,000 | +1125.0% | 78,900 | +658.7% | 0.00% | – |
| Q3 2019 | $12,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $18,984,000 | 24.27% |
| CAXTON CORP | 1,623,567 | $6,088,000 | 9.50% |
| Vivo Capital, LLC | 1,513,975 | $5,677,000 | 1.43% |
| Aisling Capital LLC | 1,804,933 | $6,768,000 | 1.16% |
| INVESTOR AB | 3,510,189 | $13,163,000 | 0.92% |
| Cormorant Asset Management, LP | 1,250,000 | $4,688,000 | 0.78% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 430,000 | $1,613,000 | 0.43% |
| PURA VIDA INVESTMENTS, LLC | 174,501 | $654,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 955,109 | $3,582,000 | 0.19% |
| ELEMENT CAPITAL MANAGEMENT LLC | 61,052 | $229,000 | 0.05% |